• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Aloka takes over U.S. sales from Corometrics

Article

Aloka announced last week that it is taking over U.S. distributionof its ultrasound scanners in ob/gyn and veterinary ultrasoundmarkets from Corometrics Medical Systems. The deal supersedesthe previous arrangement between the firms, in which Aloka

Aloka announced last week that it is taking over U.S. distributionof its ultrasound scanners in ob/gyn and veterinary ultrasoundmarkets from Corometrics Medical Systems. The deal supersedesthe previous arrangement between the firms, in which Aloka soldits scanners in radiology and intraoperative markets and Corometricsmaintained exclusive U.S. sales and marketing rights to Alokascanners in the ob/gyn and veterinary markets. Both firms arebased in Wallingford, CT.

The new structure enables the two firms to be more responsiveto customers by allowing each to focus on its core area of expertise-- Aloka in ultrasound and Corometrics in monitoring products-- according to James Pietropaolo, vice president of sales andmarketing. Corometrics will continue to provide service for allAloka ultrasound products in the U.S.

In other Aloka news, the company has announced its MultiViewupgrade for the SSD-2000 ultrasound scanners. The upgrade improvesgray-scale and color Doppler performance and includes a PowerFlowDoppler feature. All SSD-2000 units in the field are upgradableto MultiView and Aloka in August shifted production to new SSD-2000MultiView scanners.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.